Latest / US News Today | 2 Min News | The Daily News Now!
Rasonque Drug Costs $500K Yet Offers Hope | US News
A groundbreaking new drug for advanced pancreatic cancer, Rasonque, is hitting the market at a jaw-dropping $500,000 annually—but it nearly doubles survival time, extending median life to 13.2 months versus 6.7 with chemo. The company justifies the price as value-driven and promises free access for uninsured patients meeting criteria, while insurers will shoulder most of the cost. This isn’t unprecedented—several 2024 cancer drugs already exceed $400K/year, a stark contrast to the $100K+ “luxury” treatments of two decades ago. Insurers are already reviewing coverage, but strict rules could…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.